Skip to main content
Przejdź do strony domowej Komisji Europejskiej (odnośnik otworzy się w nowym oknie)
polski pl
CORDIS - Wyniki badań wspieranych przez UE
CORDIS

Siderophore-mediated delivery of antibacterial antisense agents

Cel

Antibacterial resistance represents a major and growing threat to global public health, while the development of new antibiotics with novel mechanisms of action has largely stagnated. The SIDEROSENSE project addresses this challenge by advancing a fundamentally new antibacterial modality based on antisense technology. SIDEROSENSE enables selective intracellular delivery of antibacterial antisense oligonucleotides, overcoming a long-standing barrier to the clinical translation of antisense-based antibacterials. Proof-of-principle studies have demonstrated potent antibacterial activity.

This ERC Proof of Concept project aims to establish whether the SIDEROSENSE technology translates into a safe and effective antibacterial strategy. The project will generate critical experimental data, while simultaneously strengthening the IP position and assessing regulatory and commercial pathways. In parallel, a market and exploitation strategy will be developed to support informed go/no-go decisions and downstream translation. SIDEROSENSE will deliver the essential technical and strategic validation required to assess the feasibility of antisense-based antibiotics as a new therapeutic class and to position the technology for subsequent translational funding and clinical development.

Dziedzina nauki (EuroSciVoc)

Program(-y)

Temat(-y)

System finansowania

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

Wyświetl wszystkie projekty finansowane w ramach tego programu finansowania

Zaproszenie do składania wniosków

(odnośnik otworzy się w nowym oknie) ERC-2026-POC

Wyświetl wszystkie projekty finansowane w ramach tego zaproszenia

Instytucja przyjmująca

STICHTING RADBOUD UNIVERSITEIT
Wkład UE netto
€ 150 000,00
Koszt całkowity
Brak danych

Beneficjenci (1)